Macular Edema Treatment Market Showing Compound Annual Growth Rate And Forecast Till 2026

1. Macular Edema Treatment Market - Size, Share, Macular Edema Treatment Market - Size, Share, Growth, Outlook, and Opportunity Analysis, Growth, Outlook, and Opportunity Analysis, 2018-2026 2018-2026 Macular edema is the condition characterized by abnormal leakage and accumulation of fluid that forms blister in the layer of macula. The macula is an oval-shaped pigmented area near the center of retina. This blister causes the macula to swell and thicken that causes distortion of vision. Although macular edema has numerous causes, the most common cause is diabetes. Other causes include, age-related macular degeneration, replacement of lenses in treatment of cataract, chronic uveitis and intermediate uveitis, blockage of vein in the retina, and congenital diseases including retinitis pigmentosa and retinoschisis. Symptoms of macular edema include blurry or wavy vision near or in the center of field of vision. The disease is diagnosed by performing tests such as visual acuity test, dilated eye exam,fluorescein angiogram,optical coherence tomography, andAmsler grid. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2494 Macular Edema Treatment Market: Drivers Increasing number of pipeline studies is expected to drive the macular edema treatment market growth. For instance, in April 2018, University of California, Davis, in collaboration with IRIDEX Corporation, initiated phase 3 clinical trial for Micropulse Laser Treatment to evaluate micropulse for suppression of diabetic macular edema (pulse). The primary aim of the study is to determine whether the micropulse laser treatment in eyes with good visual acuity will improve or stabilize vision loss due to the complications of diabetic macular edema. The study is expected to be completed by December 2020. Macular Edema Treatment Market: Regional Analysis On the basis of region, the global macular edema treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

2. North America is expected to account for the largest market share in the macular edema treatment market, owing to increasing prevalence of diabetic macular edema in this region. For instance, according to American Journal of Managed Care (AJMC), in 2016, the prevalence rate of diabetic macular edema was 45.3% in North America. Moreover, in 2013, as per National Center for Biotechnology Information (NCBI), around 98 million individuals reported for diabetic retinopathy (DR) and 21 million individual reported for diabetic macular edema (DME) worldwide. Report includes chapters which deeply display the following deliverable about industry : • Macular Edema Treatment Market Research Objective and Assumption • Macular Edema Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Macular Edema Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Macular Edema Treatment Market, By Regions • Macular Edema Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Macular Edema Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Macular Edema Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Macular Edema Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key players operating in the macular edema treatment market include, Novartis International AG, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Pfizer Inc. Bayer AG, Aerpio Therapeutics, Inc., Biomar Microbial Technologies, Antisense Therapeutics Limited, Coherus BioSciences, and Bausch & Lomb Incorporated.

3. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2494 Macular Edema Treatment Market Taxonomy By Disease Type Diabetic Macular Edema Cystoid Macular Edema • • By Drug Class Anti-Vascular endothelial growth factor (VEGF) injections • Avastin • Eylea • Lucentis Anti-inflammatory Medication • Nonsteroidal anti-inflammatory drugs (NSAIDs) • Corticosteroid • Ozurdex • Retisert • Iluvien • • By End User Hospitals Ophthalmic Clinics Research Institutes • • • By Region North America Europe Asia Pacific Latin America Middle East Africa • • • • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis

4. through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com